Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000351684 | SCV000345510 | uncertain significance | not provided | 2016-09-16 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002494896 | SCV002789427 | uncertain significance | Polycystic kidney disease 4 | 2021-08-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004021310 | SCV005005316 | uncertain significance | Inborn genetic diseases | 2024-01-02 | criteria provided, single submitter | clinical testing | The c.7377T>G (p.I2459M) alteration is located in exon 47 (coding exon 46) of the PKHD1 gene. This alteration results from a T to G substitution at nucleotide position 7377, causing the isoleucine (I) at amino acid position 2459 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |